These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparative Effect of rhPTH(1-84) on Bone Mineral Density and Trabecular Bone Score in Hypoparathyroidism and Postmenopausal Osteoporosis. Cipriani C, Pepe J, Silva BC, Rubin MR, Cusano NE, McMahon DJ, Nieddu L, Angelozzi M, Biamonte F, Diacinti D, Hans D, Minisola S, Bilezikian JP. J Bone Miner Res; 2018 Dec; 33(12):2132-2139. PubMed ID: 30088838 [Abstract] [Full Text] [Related]
3. Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone. Duan Y, De Luca V, Seeman E. J Clin Endocrinol Metab; 1999 Feb; 84(2):718-22. PubMed ID: 10022443 [Abstract] [Full Text] [Related]
4. Does Baseline PTH Influence Recovery of Bone Mineral Density, Trabecular Bone Score and Bone Turnover Markers? A Prospective Study Following Curative PArathyroidectomy in Primary Hyperparathyroidism. Shetty S, Cherian KE, Shetty S, Kapoor N, Jebasingh FK, Cherian A, Hephzibah J, Chandramohan A, John RA, Asha HS, Paul MJ, Manipadam MT, Abraham DT, Thomas N, Paul TV. Endocr Pract; 2020 Dec; 26(12):1442-1450. PubMed ID: 33471736 [Abstract] [Full Text] [Related]
5. Trabecular Bone Score in Obese and Nonobese Subjects With Primary Hyperparathyroidism Before and After Parathyroidectomy. Tay YD, Cusano NE, Rubin MR, Williams J, Omeragic B, Bilezikian JP. J Clin Endocrinol Metab; 2018 Apr 01; 103(4):1512-1521. PubMed ID: 29373705 [Abstract] [Full Text] [Related]
6. Primary Hyperparathyroidism: Assessment of the Effects of Parathyroidectomy Using Dual X-Ray Absorptiometry, Trabecular Bone Score, and Dual X-Ray Absorptiometry-Based Three-Dimensional Modeling. Arboiro-Pinel R, Mahillo-Fernández I, Díaz-Curiel M. Endocr Pract; 2024 Apr 01; 30(4):340-347. PubMed ID: 38184238 [Abstract] [Full Text] [Related]
7. Trabecular Bone Score, Bone Mineral Density and Bone Markers in Patients with Primary Hyperparathyroidism 2 Years After Parathyroidectomy. Miguel GA, Carranza FH, Rodríguez JCR, Ramos MA, Pablos DL, Herrero EF, Díaz-Guerra GM. Horm Metab Res; 2019 Mar 01; 51(3):186-190. PubMed ID: 30861565 [Abstract] [Full Text] [Related]
8. Effect of Endogenous Parathyroid Hormone on Bone Geometry and Skeletal Microarchitecture. Hong AR, Lee JH, Kim JH, Kim SW, Shin CS. Calcif Tissue Int; 2019 Apr 01; 104(4):382-389. PubMed ID: 30659307 [Abstract] [Full Text] [Related]
9. Changes in Skeletal Microstructure Through Four Continuous Years of rhPTH(1-84) Therapy in Hypoparathyroidism. Cusano NE, Rubin MR, Williams JM, Agarwal S, Tabacco G, Tay D, Majeed R, Omeragic B, Bilezikian JP. J Bone Miner Res; 2020 Jul 01; 35(7):1274-1281. PubMed ID: 32155287 [Abstract] [Full Text] [Related]
10. The Effects of Long-term Administration of rhPTH(1-84) in Hypoparathyroidism by Bone Histomorphometry. Rubin MR, Zhou H, Cusano NE, Majeed R, Omeragic B, Gomez M, Nickolas TL, Dempster DW, Bilezikian JP. J Bone Miner Res; 2018 Nov 01; 33(11):1931-1939. PubMed ID: 29972871 [Abstract] [Full Text] [Related]
11. Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure. Gafni RI, Brahim JS, Andreopoulou P, Bhattacharyya N, Kelly MH, Brillante BA, Reynolds JC, Zhou H, Dempster DW, Collins MT. J Bone Miner Res; 2012 Aug 01; 27(8):1811-20. PubMed ID: 22492501 [Abstract] [Full Text] [Related]
12. The Clinical and Skeletal Effects of Long-Term Therapy of Hypoparathyroidism With rhPTH(1-84). Agarwal S, McMahon DJ, Chen J, Brossfield AV, Fernando J, Bilezikian JP, Cusano NE, Rubin MR. J Bone Miner Res; 2023 Apr 01; 38(4):480-492. PubMed ID: 36726204 [Abstract] [Full Text] [Related]
13. Bone mineral density changes after parathyroidectomy are dependent on biochemical profile. Lee D, Walker MD, Chen HY, Chabot JA, Lee JA, Kuo JH. Surgery; 2019 Jan 01; 165(1):107-113. PubMed ID: 30327189 [Abstract] [Full Text] [Related]
17. Effect of parathyroidectomy on bone mineral density in hemodialysis patients with secondary hyperparathyroidism: possible usefulness of preoperative determination of parathyroid hormone level for prediction of bone regain. Yano S, Sugimoto T, Tsukamoto T, Yamaguchi T, Hattori T, Sekita KI, Kaji H, Hattori S, Kobayashi A, Chihara K. Horm Metab Res; 2003 Apr 01; 35(4):259-64. PubMed ID: 12778370 [Abstract] [Full Text] [Related]
18. Effects of Parathyroid Hormone Administration on Bone Strength in Hypoparathyroidism. Rubin MR, Zwahlen A, Dempster DW, Zhou H, Cusano NE, Zhang C, Müller R, Bilezikian JP. J Bone Miner Res; 2016 May 01; 31(5):1082-8. PubMed ID: 26724790 [Abstract] [Full Text] [Related]
19. Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study. Clarke BL, Vokes TJ, Bilezikian JP, Shoback DM, Lagast H, Mannstadt M. Endocrine; 2017 Jan 01; 55(1):273-282. PubMed ID: 27734257 [Abstract] [Full Text] [Related]
20. Therapy of Hypoparathyroidism With PTH(1-84): A Prospective Six Year Investigation of Efficacy and Safety. Rubin MR, Cusano NE, Fan WW, Delgado Y, Zhang C, Costa AG, Cremers S, Dworakowski E, Bilezikian JP. J Clin Endocrinol Metab; 2016 Jul 01; 101(7):2742-50. PubMed ID: 27144931 [Abstract] [Full Text] [Related] Page: [Next] [New Search]